Read the latest newsletter from both our MID-Frail and Frailomic initiatives here [1]. The most recent newsletter from Niche contains news from Frailomic consortium and combines recent updates on the MID-Frail project. Following a challenging start, the subject recruitment phase of the MID-Frail study has finally closed. As the MID-frail recruitment period was extended the project leadership teams have agreed to combine resources for reporting in project coordination considering the overlap in interests and team members. It was agreed by the Frailomic project lead, Professor Leocadio Rodriguez-Manãs that combining important updates in a joint newsletter would be a great way to continue sharing project information among the teams.
In this edition, we report on the Frailomic meetings held last year in Geneva, Switzerland on the 15th–16th October 2015 and in Mallorca on the 12th–13th November 2015. These meetings mark an important milestone for the beginning of the Frailomic project’s second phase. At the meetings the Frailomic consortium teams shared how they have been actively producing manuscripts, posters and abstracts to publicise the work being undertaken by the initiative. Attendees engaged in updating the consortium's publication plan and explored potential future activities to promote the projects findings.
The newsletter shares the final subject number of patients recruited to the MID-Frail study. The newsletter also includes a list of upcoming conferences as a new resource which partners may find useful in planning future presentations. More information can be found on the consortium websites [2,3].
References
Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter
The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.
Every year, a huge amount of scientific data is released. It's out there, but how do you find it?
Investigator-Initiated Clinical Trials (IITs) are clinical studies led by academic researchers or clinicians
ive years ago I was lucky enough to be involved in a project that resulted in publications
It was encouraging to see so many partners at the 2017 General Assembly meeting last December
Investigator sites are very important to clinical studies because they make sure that new drugs are safe and work well.
Get our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
